Good Morning Everyone!

Last Thursday, Jackie Iversen RPh MS, Co-Founder and Chief Clinical Officer at Sen-Jam Pharmaceutical, shared her views on the massive Common Cold market. It was a lively discussion that we wholeheartedly recommend you watch or even listen Podcast-style to this hour long dialogue.

You can do so HERE.

In this chat, Jackie discussed the fact that there has been very little, if any, real innovation in this market for over 50 years. And that a recent decision by the FDA on phenylephrine poses a real challenge for the OTC market; which represents over $10B in the US alone. Related to that news, Jackie's article on the topic which was published by Pharmacy Times can be read HERE. She futher discussed the SJP Common Cold therapeutic which is being developed with quite promising results so far.

Thank you all so much for the continued amazing support. Our story is an important one and the traction we are gaining with our mission to change the course of inflammation is illuminating a massively beautiful future.

Let's do this!

Jim